Star-Peptide Polymers are Multi-Drug-Resistant Gram-Positive Bacteria Killers

ACS Appl Mater Interfaces. 2022 Jun 8;14(22):25025-25041. doi: 10.1021/acsami.1c23734. Epub 2022 May 2.

Abstract

Antibiotic resistance in bacteria, especially Gram-positive bacteria like Staphylococcus aureus, is gaining considerable momentum worldwide and unless checked will pose a global health crisis. With few new antibiotics coming on the market, there is a need for novel antimicrobial materials that target and kill multi-drug-resistant (MDR) Gram-positive pathogens like methicillin-resistant Staphylococcus aureus (MRSA). In this study, using a novel mixed-bacteria antimicrobial assay, we show that the star-peptide polymers preferentially target and kill Gram-positive pathogens including MRSA. A major effect on the activity of the star-peptide polymer was structure, with an eight-armed structure inducing the greatest bactericidal activity. The different star-peptide polymer structures were found to induce different mechanisms of bacterial death both in vitro and in vivo. These results highlight the potential utility of peptide/polymers to fabricate materials for therapeutic development against MDR Gram-positive bacterial infections.

Keywords: Gram-positive; Staphylococcus aureus; antibiotic; antimicrobial resistance; membrane active; nanoengineered peptide polymer.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents* / pharmacology
  • Bacteria
  • Gram-Positive Bacteria
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Peptides / pharmacology
  • Polymers / pharmacology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Peptides
  • Polymers